Stereotaxis is trading at $1.38, up +5.34%, with no clear company-specific catalyst identified for its September 25 after-hours move.
- No clear Stereotaxis announcement or other company-specific catalyst surfaced in available coverage; the latest identified company announcement was dated September 16 and concerned a planned HRX 2026 technology showcase.
- The broader market rose September 25, with supplied index figures up 0.64% to 0.93%; this does not establish a cause for the after-hours gain.